Old Web
English
Sign In
Acemap
>
authorDetail
>
N. F. Abdel Karim
N. F. Abdel Karim
Medicine
Pathology
Oncology
VEGF receptors
Internal medicine
4
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A closer look at the number of lymph nodes examined in colorectal cancer: A VAMC experience
2016
Journal of Clinical Oncology
J. M. Kovar
H. X. Bui
J. P. Reynolds
H. Al-Ghawi
G. Luo
N. F. Abdel Karim
S. Samaan
A. Mehta
M. Molloy
Show All
Source
Cite
Save
Citations (0)
EML4-ALK in NSCLC: The OSU Experience.
2011
Journal of Clinical Oncology
Erin M. Bertino
Weiqiang Zhao
Miguel A. Villalona-Calero
N. F. Abdel Karim
Konstantin Shilo
G. A. Otterson
Show All
Source
Cite
Save
Citations (1)
Phase II trial of nab-paclitaxel plus carboplatin for advanced NSCLC in patients at risk of bleeding from VEGF-directed therapies.
2010
Journal of Clinical Oncology
Erin M. Bertino
G. A. Otterson
Miguel A. Villalona-Calero
Serge P. Nana-Sinkam
A. M. Ghany
K. R. Donthireddy
N. F. Abdel Karim
S. Cantrell
Gary Phillips
Show All
Source
Cite
Save
Citations (1)
ERCC1, VEGF along with clinical variants impact the outcome of advanced non-small cell lung cancer (NSCLC) patients
2009
Journal of Clinical Oncology
N. F. Abdel Karim
Hai Bui
Ninad Patil
Peterson Pathrose
M.B Rao
Ahmed Mostafa
A Mehta
Marshall W. Anderson
Show All
Source
Cite
Save
Citations (0)
1